Compare SPOK & CNTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPOK | CNTN |
|---|---|---|
| Founded | 2004 | 2017 |
| Country | United States | United States |
| Employees | N/A | 12 |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.8M | 178.5M |
| IPO Year | 2004 | 2021 |
| Metric | SPOK | CNTN |
|---|---|---|
| Price | $10.38 | $2.36 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | 108.8K | ★ 584.7K |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | ★ 11.31% | N/A |
| EPS Growth | 2.74 | ★ 88.10 |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $139,708,000.00 | N/A |
| Revenue This Year | $1.70 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $35.86 | ★ N/A |
| Revenue Growth | ★ 1.49 | N/A |
| 52 Week Low | $9.95 | $1.75 |
| 52 Week High | $17.53 | $5.27 |
| Indicator | SPOK | CNTN |
|---|---|---|
| Relative Strength Index (RSI) | 44.62 | 51.80 |
| Support Level | $10.29 | $2.14 |
| Resistance Level | $10.83 | $2.40 |
| Average True Range (ATR) | 0.17 | 0.14 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 30.88 | 52.14 |
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.